1. Home
  2. NEO vs BTZ Comparison

NEO vs BTZ Comparison

Compare NEO & BTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$7.90

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Credit Allocation Income Trust

BTZ

BlackRock Credit Allocation Income Trust

HOLD

Current Price

$10.02

Market Cap

998.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
BTZ
Founded
2001
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
998.6M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NEO
BTZ
Price
$7.90
$10.02
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$11.14
N/A
AVG Volume (30 Days)
2.0M
307.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
9.40%
EPS Growth
N/A
N/A
EPS
N/A
1.41
Revenue
N/A
N/A
Revenue This Year
$10.63
N/A
Revenue Next Year
$9.73
N/A
P/E Ratio
N/A
$7.14
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$9.54
52 Week High
$13.74
$11.18

Technical Indicators

Market Signals
Indicator
NEO
BTZ
Relative Strength Index (RSI) 19.28 17.83
Support Level $7.07 N/A
Resistance Level $8.89 $10.84
Average True Range (ATR) 0.47 0.10
MACD -0.11 -0.06
Stochastic Oscillator 2.30 2.76

Price Performance

Historical Comparison
NEO
BTZ

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About BTZ BlackRock Credit Allocation Income Trust

Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.

Share on Social Networks: